# Study of AERAS-402 in Healthy Infants

> **NCT01198366** · PHASE1,PHASE2 · COMPLETED · sponsor: **Aeras** · enrollment: 487 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** AERAS-402 1.5 x 10^10 vp
- **BIOLOGICAL:** AERAS-402 3.0 x 10^10 vp
- **BIOLOGICAL:** AERAS-402 1.0 x 10^11 vp
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01198366
- **Lead sponsor:** Aeras
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-04
- **Target enrollment:** 487 (ACTUAL)
- **Last updated:** 2017-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198366, "Study of AERAS-402 in Healthy Infants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01198366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*